Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder

NCT06557902 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: Lumateperone 10.5 mg capsule
DRUG: Lumateperone 21 mg capsule
DRUG: Lumateperone 5 mg ODT
DRUG: Lumateperone 10.5 mg ODT
DRUG: Lumateperone 15.5 mg ODT
DRUG: Lumateperone 21 mg ODT

Sponsor

Intra-Cellular Therapies, Inc.